Project Grant HT94252410757
Award Date 7/15/24
Completion Date 7/14/26
Dollars Obligated $1.3M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
- Yale University received a $1,351,106 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award beginning July 1, 2023 will support research to identify circuit mechanisms of MDMA and methylone in order to develop plasticity-based post-traumatic stress disorder (PTSD) treatment. Through this funding, Yale researchers will investigate medical solutions applicable to battlefield conditions by...
- Summary Yale University received a $1.675 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct drug discovery research for dystonia and frontotemporal degeneration. The award, issued on August 15, 2025, supports a four-year research initiative extending through August 14, 2029, with research activities to be performed at Yale's Hamden, Connecticut location. This project contributes to the DHA's...
- Federal Project Grant Award Summary Yale University received a $1.25 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2026, through June 30, 2029. The award supports research targeting KDM5 histone demethylases as a therapeutic approach to treat breast cancer. This three-year research initiative will be conducted at Yale's Hamden, Connecticut location and represents DHA's investment in advanced...
- The U.S. Department of Defense, through its Military Medical Research and Development program (CFDA 12.420), awarded a $460,279 Project Grant to Yale University on February 15, 2025. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, titled "LOSS OF PROTEOSTASIS AND VASCULAR AMYLOIDOSIS," focuses on investigating medical solutions for the battlefield and developing...
- Federal Grant Award Summary Yale University received a $670,917 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 15, 2025, through June 14, 2027. The award supports research titled "Exploiting METTL3 Inhibition-Induced Dysregulation of DNA Repair in the Treatment of Leukemia," conducted at Yale's Hamden, Connecticut location. This research project investigates novel therapeutic...
- The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,235,447 Project Grant to Yale University on July 1, 2023. This 3-year grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support research targeting the chromatin regulator WDR5 to treat breast cancer metastasis. The project aims to transform health care for service members and the general public through innovative and impactful biomedical research investigating medical solutions for the...
- The Defense Health Agency has awarded a $1,674,999.00 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). The grant is for the "PERTURBOMICS IDENTIFICATION OF CRITICAL GENETIC TARGETS IN NK CELLS FOR BREAST CANCER THERAPY" project, which will be conducted from September 1, 2023 to August 31, 2026. The funding will support basic, applied, and advanced biomedical research to transform healthcare for service members and the public...
- The Defense Health Agency awarded Yale University a 3-year, USD 1,277,053 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to target the chromatin regulator WDR5 to treat breast cancer metastasis. The project aims to advance the understanding and development of novel therapeutic approaches for breast cancer, a leading cause of cancer-related deaths. As the prime awardee, Yale University will conduct the research, development, and testing activities...
- Duke University was awarded a $1,608,140 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2026 to develop non-opioid G protein-coupled receptor signaling-biased agents for pain management. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and...